Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-09 to 2023-05-10
Current total value of award: $583.98
Description: 4560874198!QUILLIVANT XR ORAL SUSP 120ML 5MG/ML